BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8969443)

  • 1. Successful treatment of primary cutaneous Aspergillus flavus infection of the hand with oral itraconazole.
    Epstein MD; Segalman KA; Mulholland JH; Orbegoso CM
    J Hand Surg Am; 1996 Nov; 21(6):1106-8. PubMed ID: 8969443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous aspergillosis.
    Nakashima K; Yamada N; Yoshida Y; Yamamoto O
    Acta Derm Venereol; 2010 Sep; 90(5):519-20. PubMed ID: 20814631
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of invasive cavernous sinus aspergillosis with oral itraconazole monotherapy.
    Browning AC; Sim KT; Timms JM; Vernon SA; McConachie NS; Allibone R; Jones NS
    J Neuroophthalmol; 2006 Jun; 26(2):103-6. PubMed ID: 16845309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic infection of Aspergillus flavus in a patient with acute lymphoblastic leukemia].
    Narimatsu H; Morishita Y; Kohno A; Saito S; Shimada K; Ozeki K; Funahashi K; Kato Y
    Rinsho Ketsueki; 2003 Oct; 44(10):1026-31. PubMed ID: 14639950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
    Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
    Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of aspergillus bronchitis with effective oral itraconazole].
    Oonakahara K; Mizoguchi A; Iwami F; Kawabata M; Osame M
    Nihon Kokyuki Gakkai Zasshi; 2003 Apr; 41(4):282-7. PubMed ID: 12795183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated renoureteric aspergilloma due to Aspergillus flavus: case report and review of the literature.
    Pérez-Arellano JL; Angel-Moreno A; Belón E; Francès A; Santana OE; Martín-Sánchez AM
    J Infect; 2001 Feb; 42(2):163-5. PubMed ID: 11531327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspergillus vertebral osteomyelitis and ureteral obstruction after liver transplantation.
    Zhu LP; Chen XS; Wu JQ; Yang FF; Weng XH
    Transpl Infect Dis; 2011 Apr; 13(2):192-9. PubMed ID: 21457422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous aspergillosis in renal transplant recipient.
    Gupta A; Khaira A; Lata S; Sharma A; Tiwari SC
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):848-9. PubMed ID: 19736488
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pseudotumoral naso-sinusal aspergillosis stabilized by itraconazole].
    Gresenguet G; Belec L; Testat J; Lesbordes JL; Dupont B; Georges AJ
    Med Trop (Mars); 1989; 49(1):73-5. PubMed ID: 2542719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
    Paterson PJ; Seaton S; Prentice HG; Kibbler CC
    J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative treatment of malignant (invasive) external otitis caused by Aspergillus flavus with oral itraconazole solution in a neutropenic patient.
    Finer G; Greenberg D; Leibovitz E; Leiberman A; Shelef I; Kapelushnik J
    Scand J Infect Dis; 2002; 34(3):227-9. PubMed ID: 12030404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of extensive onychomycosis in aged patients].
    Maleszka R; Adamski Z
    Wiad Parazytol; 2001; 47(4):817-22. PubMed ID: 16886433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activity of a liposomal itraconazole formulation in experimental Aspergillus flavus keratitis with endophthalmitis.
    Leal AF; Leite MC; Medeiros CS; Cavalcanti IM; Wanderley AG; Magalhães NS; Neves RP
    Mycopathologia; 2015 Apr; 179(3-4):225-9. PubMed ID: 25431088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
    De Rosso JQ; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():46-52. PubMed ID: 10492666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Fingernail Onychomycosis due to Aspergillus flavus.
    Noguchi H; Hiruma M; Miyashita A; Makino K; Miyata K; Ihn H
    Med Mycol J; 2016; 57(2):E21-5. PubMed ID: 27251317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated aspergillosis due to Aspergillus flavus in an experimental model: efficacy of azole therapy.
    Kaliamurthy J; Geraldine P; Thomas PA
    Mycoses; 2003 Jun; 46(5-6):174-82. PubMed ID: 12801358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated nasopharyngeal aspergillosis caused by A flavus and associated with oxalosis.
    Dogan M; Pabuçcuoglu U; Sarioglu S; Yücesoy M
    Ear Nose Throat J; 2004 May; 83(5):331-3. PubMed ID: 15195880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.